Literature DB >> 22441160

Tuberculosis vaccines: a strategic blueprint for the next decade.

Michael J Brennan1, Jelle Thole.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22441160     DOI： 10.1016/S1472-9792(12)70005-7

Source DB:  PubMed          Journal:  Tuberculosis (Edinb)        ISSN： 1472-9792            Impact factor:   3.131


× No keyword cloud information.
  53 in total

Review 1.  Recent Trends in System-Scale Integrative Approaches for Discovering Protective Antigens Against Mycobacterial Pathogens.

Authors:  Aarti Rana; Shweta Thakur; Girish Kumar; Yusuf Akhter
Journal:  Front Genet       Date:  2018-11-27       Impact factor: 4.599

2.  A multistage mycobacterium tuberculosis subunit vaccine LT70 including latency antigen Rv2626c induces long-term protection against tuberculosis.

Authors:  Xun Liu; Jinxiu Peng; Lina Hu; Yanping Luo; Hongxia Niu; Chunxiang Bai; Qian Wang; Fei Li; Hongjuan Yu; Bingxiang Wang; Huiyu Chen; Ming Guo; Bingdong Zhu
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

Review 3.  Early clearance of Mycobacterium tuberculosis: a new frontier in prevention.

Authors:  Ayesha J Verrall; Mihai G Netea; Bachti Alisjahbana; Philip C Hill; Reimout van Crevel
Journal:  Immunology       Date:  2014-04       Impact factor: 7.397

4.  High mobility group box 1 acts as an adjuvant for tuberculosis subunit vaccines.

Authors:  Ajay Grover; Jolynn Troudt; Chad Foster; Randall Basaraba; Angelo Izzo
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

5.  Willingness to participate in trials and to be vaccinated with new tuberculosis vaccines in HIV-infected adults.

Authors:  T Kufa; V Chihota; S Charalambous; S Verver; G Churchyard
Journal:  Public Health Action       Date:  2013-03-21

6.  Enhancement of Antituberculosis Immunity in a Humanized Model System by a Novel Virus-Vectored Respiratory Mucosal Vaccine.

Authors:  Yushi Yao; Rocky Lai; Sam Afkhami; Siamak Haddadi; Anna Zganiacz; Fatemeh Vahedi; Ali A Ashkar; Charu Kaushic; Mangalakumari Jeyanathan; Zhou Xing
Journal:  J Infect Dis       Date:  2017-07-01       Impact factor: 5.226

7.  Induction of an Immune-Protective T-Cell Repertoire With Diverse Genetic Coverage by a Novel Viral-Vectored Tuberculosis Vaccine in Humans.

Authors:  Mangalakumari Jeyanathan; Daniela Damjanovic; Yushi Yao; Jonathan Bramson; Fiona Smaill; Zhou Xing
Journal:  J Infect Dis       Date:  2016-10-04       Impact factor: 5.226

8.  Immunogenic Properties of Lactobacillus plantarum Producing Surface-Displayed Mycobacterium tuberculosis Antigens.

Authors:  Katarzyna Kuczkowska; Charlotte R Kleiveland; Rajna Minic; Lars F Moen; Lise Øverland; Rannei Tjåland; Harald Carlsen; Tor Lea; Geir Mathiesen; Vincent G H Eijsink
Journal:  Appl Environ Microbiol       Date:  2016-12-30       Impact factor: 4.792

9.  Therapeutic vaccination against relevant high virulence clinical isolates of Mycobacterium tuberculosis.

Authors:  Crystal A Shanley; Gregory C Ireton; Susan L Baldwin; Rhea N Coler; Steven G Reed; Randall J Basaraba; Ian M Orme
Journal:  Tuberculosis (Edinb)       Date:  2013-09-07       Impact factor: 3.131

10.  Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis.

Authors:  Mark T Orr; Gregory C Ireton; Elyse A Beebe; Po-Wei D Huang; Valerie A Reese; David Argilla; Rhea N Coler; Steven G Reed
Journal:  J Immunol       Date:  2014-08-01       Impact factor: 5.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.